HSBC TO. BULL VX1/ DE000TR0YFR0 /
2024-04-19 9:35:07 PM | Chg.-0.170 | Bid9:46:49 PM | Ask9:46:49 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
23.000EUR | -0.73% | 22.980 Bid Size: 25,000 |
23.010 Ask Size: 25,000 |
Vertex Pharmaceutica... | 149.408 USD | 2078-12-31 | Call |
GlobeNewswire
04-09
American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated...
GlobeNewswire
04-03
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
GlobeNewswire
04-01
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
GlobeNewswire
04-01
CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Me...
GlobeNewswire
03-15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
03-13
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire
03-12
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
GlobeNewswire
03-12
UNCF 80th Anniversary Gala in Boston Raises More than $750K to Support HBCUs and Students
GlobeNewswire
02-29
Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire
02-28
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
GlobeNewswire
02-27
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financia...
GlobeNewswire
02-26
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as...
GlobeNewswire
02-21
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial...
GlobeNewswire
02-15
CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit
GlobeNewswire
02-13
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemc...
GlobeNewswire
01-25
American Kidney Fund Announces April 30 as the First Annual APOL1-Mediated Kidney Disease (AMKD) Awa...
GlobeNewswire
01-16
CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY™ (exagamgl...